Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ITPR1 | Q14643 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13485129 | 0.96 | KMT2A (0.63) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL9999823 | 0.93 | KMT2A (0.61) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL22548288 | 0.90 | MEN1 (0.55) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL31029916 | 0.90 | MEN1 (0.55) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL24608832 | 0.87 | MEN1 (0.52) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL19000753 | 0.86 | KMT2A (0.62) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL2181341 | 0.86 | KMT2A (0.65) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL16192993 | 0.85 | KMT2A (0.68) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL8979409 | 0.84 | KMT2A (0.67) | KMT2AMEN1ALDH1A1MTNR1AHPGD | |
| SCHEMBL1275257 | 0.83 | KMT2A (0.62) | KMT2AMEN1ALDH1A1MTNR1AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109534331-A | The preparation method of pyrenyl quaternary ammonium salt modification supercapacitor graphene dispersing solution | 渤海大学 | 2019-03-29 | — | — | CN | claimed |
| US-11617804-B2 | Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith | WAKE FOREST UNIVERSITY (US) | 2023-04-04 | — | — | US | disclosed |
| US-11617804-B2 | Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith | WAKE FOREST UNIVERSITY (US) | 2023-04-04 | — | — | US | disclosed |
| US-11370950-B2 | Surface-modified inorganic nitride, composition, thermally conductive material, and device with thermally conductive layer | FUJIFILM CORPORATION (JP) | 2022-06-28 | — | — | US | disclosed |
| US-10889554-B2 | Excimer forming compounds | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2021-01-12 | — | — | US | disclosed |
| US-20200140738-A1 | SURFACE-MODIFIED INORGANIC NITRIDE, COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER | FUJIFILM CORPORATION (JP) | 2020-05-07 | — | — | US | disclosed |
| CN-109534331-A | The preparation method of pyrenyl quaternary ammonium salt modification supercapacitor graphene dispersing solution | 渤海大学 | 2019-03-29 | — | — | CN | disclosed |
| CN-109534331-A | The preparation method of pyrenyl quaternary ammonium salt modification supercapacitor graphene dispersing solution | 渤海大学 | 2019-03-29 | — | — | CN | disclosed |
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | WAKE FOREST UNIVERSITY | 2017-07-20 | — | — | US | disclosed |
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | WAKE FOREST UNIVERSITY | 2017-07-20 | — | — | US | disclosed |
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | WAKE FOREST UNIVERSITY | 2017-07-20 | — | — | US | disclosed |
| US-7459263-B2 | Optical recording media with triplet-sensitized isomerization | EASTMAN KODAK COMPANY (US) | 2008-12-02 | — | — | US | disclosed |
| US-7459263-B2 | Optical recording media with triplet-sensitized isomerization | EASTMAN KODAK COMPANY (US) | 2008-12-02 | — | — | US | disclosed |
| US-7301043-B2 | Compounds for determining the activity of phospholipase A2 | SIRS-LAB GMBH (DE) | 2007-11-27 | — | — | US | disclosed |
| US-6916920-B2 | Process for producing hydrazinomonosaccharide derivatives and use thereof | TAKARA BIO INC. (JP) | 2005-07-12 | — | — | US | disclosed |
| US-20040006221-A1 | Process for producing hydrazinomonosaccharide derivatives and use thereof | TAKARA BIO INC. (JP) | 2004-01-08 | — | — | US | disclosed |
| EP-1310503-A1 | PROCESS FOR PRODUCING HYDRAZINOMONOSACCHARIDE DERIVATIVES AND USE THEREOF | TAKARA BIO INC. (JP) | 2003-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202982-A1 | Hyaluronic Acid-Based Nanoparticles as Biosensors for Imaging-Guided Surgery and Drug Delivery Vehicles and Methods Associated Therewith | CD44, HLA-A, HLA-C | KMT2A 3230/4885MEN1 1804/4885ALDH1A1 255/4885 |
| US-10889554-B2 | Excimer forming compounds | PHAX, RNMT, POLM | KMT2A 4495/4885MEN1 2014/4885ALDH1A1 4820/4885 |
| US-11617804-B2 | Hyaluronic acid-based nanoparticles as biosensors for imaging-guided surgery and drug delivery vehicles and methods associated therewith | CD44, HLA-A, HLA-C | KMT2A 3230/4885MEN1 1804/4885ALDH1A1 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.